11-BETA-HYDROXYSTEROID DEHYDROGENASE-1-INHIBITOR-DIABETES-TYPE 2-1

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for ex...

Full description

Saved in:
Bibliographic Details
Main Authors BILOTTA, JOSEPH ANTHONY, TILLEY, JEFFERSON WRIGHT, PIETRANICO-COLE, SHERRIE LYNN, FOTOUHI, NADER, MYERS, MICHAEL PAUL, GILLESPIE, PAUL, GOODNOW JR., ROBERT ALAN, HAYNES, NANCY-ELLEN, KOWALCZYK, AGNIESZKA, BANNER, BRUCE LESTER, SCOTT, NATHAN ROBERT, THAKKAR, KSHITIJ CHHABILBHAI, MAYWEG, ALEXANDER V, GUERTIN, KEVIN RICHARD, HAMILTON, MATTHEW MICHAEL
Format Patent
LanguageEnglish
French
German
Published 31.07.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
Bibliography:Application Number: EP20060792922